Definitive Healthcare Corp. (NASDAQ:DH) Receives Consensus Recommendation of "Reduce" from Analysts

Key Points

• Definitive Healthcare Corp. has received a consensus recommendation of "Reduce" from analysts, with two sell, four hold, and one buy rating noted amongst seven research firms.
• The average price target among analysts for Definitive Healthcare is currently $4.28, with recent targets ranging from $4.00 to $6.00.
• Institutional investors own 98.67% of Definitive Healthcare's stock, indicating significant institutional interest and investment in the company.

Shares of Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) have earned an average rating of "Reduce" from the seven research firms that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $4.28.

A number of equities research analysts have recently weighed in on the company. Robert W. Baird set a $4.00 target price on Definitive Healthcare in a research note on Friday, August 8th. Stifel Nicolaus lifted their price target on Definitive Healthcare from $5.00 to $6.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Definitive Healthcare in a research note on Friday.

Institutional Investors Weigh In On Definitive Healthcare

A number of large investors have recently added to or reduced their stakes in the company. New York State Common Retirement Fund boosted its holdings in shares of Definitive Healthcare by 0.4% during the second quarter. New York State Common Retirement Fund now owns 766,433 shares of the company's stock worth $2,989,000 after purchasing an additional 3,066 shares during the period. Raymond James Financial Inc. bought a new position in Definitive Healthcare during the 2nd quarter valued at approximately $32,000. Creative Planning raised its position in Definitive Healthcare by 41.7% during the 2nd quarter. Creative Planning now owns 28,628 shares of the company's stock valued at $112,000 after purchasing an additional 8,428 shares during the last quarter. Farther Finance Advisors LLC purchased a new stake in Definitive Healthcare in the 2nd quarter worth approximately $33,000. Finally, Heron Bay Capital Management grew its position in shares of Definitive Healthcare by 43.0% in the 2nd quarter. Heron Bay Capital Management now owns 28,651 shares of the company's stock worth $112,000 after buying an additional 8,615 shares during the last quarter. Institutional investors own 98.67% of the company's stock.

Definitive Healthcare Price Performance

Shares of NASDAQ:DH opened at $2.97 on Friday. The stock has a market cap of $425.13 million, a PE ratio of -1.12 and a beta of 1.65. The company's fifty day moving average is $3.69 and its 200 day moving average is $3.54. Definitive Healthcare has a 52 week low of $2.15 and a 52 week high of $5.68. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.39.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.